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abstract
Objective. explore the situations in which gPs associate drug use with falls among their elderly patients, and the factors influ-
encing the prescribing and cessation of fall-risk-increasing drugs (FrIDs). Design. A qualitative study with 13 gPs who 
participated in two semi-structured focus groups in Central Norway. Participants were encouraged to share overall thoughts 
on the use of FrIDs among elderly patients and stories related to prescribing and cessation of FrIDs in their own practice. 
Results. The main finding was that gPs did not immediately perceive the use of FrIDs to be a prominent factor regarding 
falls in elderly patients, exceptions being when the patient presented with dizziness, reported a fall, or when prescribing FrIDs 
for the first time. It was reported as common to renew prescriptions without performing a drug review. Factors influencing 
the prescribing and cessation of FrIDs were categorized into gPs’ clinical work conditions, uncertainty about outcome of 
changing prescriptions, patients’ prescribing demands, and lack of patient information. Conclusions. The results from this study 
indicate that gPs need to be reminded that there is a connection between FrID use and falls among elderly patients of 
enough clinical relevance to remember to assess the patient’s drug list and perform regular drug reviews.
Key Words: Drug review, elderly, falls, general practitioner, inappropriate prescribing, primary care, qualitative, Norway
general practitioners (gPs) usually manage the 
whole treatment, including medication management, 
for the elderly living at home, and they are therefore 
the main prescribers of FrIDs. Prescribing patterns in 
general practice vary and cannot be accounted for on 
purely pharmacological grounds [11]. Inappropriate 
prescribing of benzodiazepines and z-hypnotics for the 
elderly is common despite guidelines advising the con-
trary [12] and many physicians have poor knowledge 
of guidelines or are unaware of them [13]. general 
practitioners report that they experience conflicts 
between adhering to national guidelines and follow 
the patient’s preferences [14].
However, there is still a lack of studies exploring 
the gPs’ motives for providing medical prescriptions 
[15]. knowledge regarding whether the gPs associ-
ate drug use with falls and how this might affect 
clinical practice is thus important. The aim of this 
introduction
Injuries caused by falls are one of the leading causes 
of death in elderly, and often lead to longstanding 
pain and disability [1,2]. The underlying causes of 
falls are multifaceted, including a combination of 
biological and environmental factors [3]. A number 
of drugs called fall-risk-increasing drugs (FrIDs), 
mainly those affecting the cardiovascular and the 
central nervous system, have been found to increase 
the risk of falls [3–6].
Inappropriate prescribing occurs commonly 
among elderly patients [7–9]. The sum of multiple 
disease, changed metabolism of drugs, and insuffi-
cient knowledge concerning how to use the drugs 
puts the elderly at higher risk for adverse drug events 
such as falls. The consequences of such adverse drug 
events are also decreased quality of life and high cost 
of health care [10].
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study was therefore to explore whether gPs associate 
drug use with falls among their elderly patients, and 
the factors influencing prescribing and cessation of 
FrIDs.
Material and methods
This was a qualitative study with focus-group inter-
views of gPs held in Central Norway during May 
and June 2013. The regional ethics Committee for 
research in Medicine of Central Norway approved 
the study, and the participating gPs signed written 
consent.
Setting
In Norway, all citizens are entitled to have a gP 
who is responsible for providing general healthcare, 
and 99.6% of the population were registered with 
a personal gP by the end of 2012. In 2009 the 
elderly above 60 years had on average more than 
three consultations per year and those above 80 
years up to five [16]. gPs have access to support 
tools for prescribing and cessation of possible inap-
propriate drugs for elderly, such as the NOrgeP 
criteria (Norwegian general Practice Criteria) 
[17], the STArT/STOP criteria (Screening Tool to 
Alert doctors to the right Treatment/Screening 
Tool of Older People’s potentially inappropriate 
Prescriptions) [18], checklist on how to perform 
drug reviews [19] and the National guidelines 
on the Use of Habit Forming Drugs [20]. The 
latter includes the driving licence regulation, 
which explains explicitly how much of a specific 
prescription drug a driver is allowed to use whilst 
driving.
New gP legislation from 2013 states that for 
patients who use four or more drugs the gP is sup-
posed to perform drug reviews when considered nec-
essary from a medical point of view [21]. However, 
this regulation does not state the frequency of drug 
reviews or whether they should be multidisciplinary.
Informants
The aim was to recruit gPs with experience in pre-
scribing for the elderly. To ensure variation, we 
recruited gPs of both genders, with different length 
of experience and from different gP offices. Partici-
pants were recruited through two peer-continued 
medical education groups (CMe). To keep their spe-
cialization, gPs in Norway are obligated to attend 
such groups at least three times, for a minimum of 
six hours, during each 12-month period [22].
Data collection
The semi-structured focus-group [23,24] interviews 
were conducted as part of an already scheduled 
CMe meeting. The interviews lasted approximately 
one hour and were led by the first author (HTB). 
The term FrIDs was accounted for by referring to 
the drug groups psychotropic drugs, antihyperten-
sive drugs, and cardiovascular drugs [25,26]. The 
open-ended questions in the interview guide used for 
this study were:
In which situations do you associate drug use  •
with falls among the elderly above 65 years and 
what factors influence your prescribing and ces-
sation of FrIDs?
What are your overall thoughts on the use of  •
FrIDs amongst elderly patients?
What are your experiences of consultations with  •
elderly patients and their next-of-kin regarding 
FrIDs?
Data analysis
The focus-group interviews were digitally recorded 
and transcribed verbatim. They were analysed using 
the method of systematic text condensation [27], 
which consists of an iterative four-step process. In 
the first step, all authors read the transcripts, and 
preliminary themes were then identified and dis-
cussed. In the second step, the transcripts were coded 
according to these themes by identifying meaning 
units and the main themes were adjusted. In the third 
step, the meaning units were arranged into subthemes 
and a condensate was made of each theme and sub-
Injuries caused by falls often lead to  •
longstanding pain and disability and are one 
of the leading causes of death in the elderly. 
Psychotropic, antihypertensive, and cardio-
vascular drugs (termed FrIDs) contribute 
to the risk of falls.
It was found that the gPs did not perceive  •
drugs as a prominent factor in causing 
falls among the elderly. It was reported as 
common practice to renew FrIDs without 
further considerations.
Access to and quality of the prescribing and  •
de-prescribing support tools, handling out-
come uncertainty, and patient demands 
were said to influence practice.
gPs need to recognize the connection  •
between FrID use and falls as of enough 
importance to change practice and perform 
regular drug reviews.
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theme. In the last step, an analytic text was produced 
based on each theme and subtheme. The themes and 
the analysis were discussed in an extended research 
group to ensure validity. During the whole process, 
the authors went back to the transcripts to ensure 
that the analysis was based on them.
results
Participant characteristics are listed in Table I. When 
starting the interviews the gPs’ immediate response 
was that they did not perceive the use of drugs among 
their elderly patients to be a prominent factor in 
causing falls. Upon reflection two exceptions were 
expressed: when they received an external probe to 
do a drug review and when they prescribed FrIDs 
for the first time. The factors influencing the pre-
scribing or cessation of FrIDs were categorized into 
the following subthemes; consultation time, guide-
lines and prescribing support, uncertainty about out-
come of change in FrIDs, patient’s demand for 
prescriptions, and not getting all information about 
the patient.
Drugs not perceived as a prominent risk factor for falls
The sum of multiple factors such as alcohol use, slip-
pery floors, domestic obstacles, multiple diseases, 
and poor quality of life were spontaneously men-
tioned by the gPs to be equal or more important 
contributors to falls than drugs. After further elabo-
ration antihypertensive drugs were also mentioned as 
a potential challenge due to orthostatic hypotensive 
side effects. Orthostatic hypotension was perceived 
to be a greater contributor to falls than the use of 
psychotropic drugs.
To be honest I believe it is the sum of many 
factors like alcohol, domestic traps, multiple 
diagnosis, and bad quality of life, due to poor 
sleep, that makes them fall. (Male gP, 10 years 
of practice)
When asked how consultations regarding FrIDs 
took place and how they communicate with the 
patient the gPs said that the majority of their elderly 
patients had used the same FrID for many years. It 
was therefore common practice to renew any pre-
scription without performing a drug review, the rea-
son being no perceived medical indication for a 
change and also reluctance to change a treatment 
that seemed to work even though they knew patients 
received potentially inappropriate prescriptions. The 
gPs would continue to prescribe FrIDs if they per-
ceived that termination of that medication would 
negatively affect the patient’s quality of life. Drug 
addiction was generally not seen as a problem in this 
patient group compared with younger patients.
long-term treatment passes by without my 
questioning. We know that inappropriate combi-
nations occur sometimes, but we daren’t make 
changes since things seem to work, at least to a 
certain extent. (Female gP, 7 years in practice)
One situation leading to a consideration of the drug 
prescribed was if a patient had fallen or had pre-
sented with symptoms such as dizziness. This infor-
mation could come from the patient, the next-of-kin 
or in a hospital discharge letter. Some gPs said they 
especially appreciated discharge letters in which 
someone had done a medical review and made sug-
gestions for alterations on their prescribing. These 
external probes triggered considerations and deci-
sions about whether to terminate the drug or change 
its dose. This made them aware of those previously 
effective drugs that might now be ineffective due to 
physiological age-related changes. It was said that 
discharge letters could serve as a general reminder of 
regular drug reviews for the elderly.
If a patient has fallen I feel guilty, and the patient’s 
medication list comes to mind as a possible expla-
nation. (Male gP, 26 years in practice)
The initiation of a new FrID was also a situation 
where drug use was linked to falls. In this case, an 
accurate diagnosis was said to be important to ensure 
correct prescribing; to do a thorough examination of 
the patient in order to ensure that there was an indi-
cation for the drug; and to exclude other possible 
explanations for the symptoms. Before prescribing 
hypnotic drugs, some gPs said they would initially 
make an effort to explain changes in sleep patterns 
due to age, to make it clear to the elderly patient that 
they could not necessarily expect to sleep as much 
as when they were younger. If the consultation 
resulted in a prescription, they would thoroughly 
explain both effects and side effects. First-time 
Table I. Participant characteristics.
Focus group 1 
n  5
Focus group 2 
n  8
Total  
n  13
Female (n) 1 2 3
Years as gP (n) 7–11 11–36 7–36
Specialist in general 
practice
4 8 12
Specialist in another 
medical discipline
1 1 2
Number of different 
gP offices
5 7 11*
 Note: *One gP from Fg1 and one from Fg2 came from the same 
gP office and two gPs in Fg2 worked at the same gP office.
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prescribing of FrIDs was perceived to occur more 
rarely than renewal of existing prescriptions.
It is very important that the diagnosis is 110% 
and that they use the drug only for a short period 
of time. Start low and go slow. (Male gP, 23 
years in practice)
Consultation time, guidelines, and prescribing support
The gPs said that the time set aside for consultations 
affected prescribing since elderly patients usually do 
not visit very often but when they do, they present 
with many issues. The perceived high workload, 
resulting in little time for each issue, was therefore 
given as a reason for renewed prescription of 
FrIDs.
If he struggles with his sleep that is only one of 
many problems. I do not arrange a new appoint-
ment to just talk about his drugs. That will be a 
complication for both him and me. (Male gP, 9 
years in practice)
existing national prescribing guidelines were not 
perceived to be suitable when prescribing drugs for 
the elderly. The reasons given were that such guide-
lines cover only one disease and therefore do not 
reflect the complexity in primary care. In addition 
elderly people with polypharmacy and multiple 
diseases were perceived as very different from 
the population the guidelines were based on. lack 
of suitable guidelines therefore contributed to the 
habit of renewing FrID prescriptions without a 
drug review. The gPs felt that if they were to follow 
all existing guidelines for a patient with multiple 
diseases the patient would be prescribed many more 
drugs than were appropriate. Some gPs also 
reflected upon the age at which they should stop 
attempting to prevent future diseases in a patient, 
since there is a trend for existing guidelines to no 
longer define an age limit.
A pull factor that could initiate change in pre-
scribing of FrIDs and other drugs was the electronic 
prescription system and the multi-dose drug-dis-
pensing system. One gP said that these two systems 
improved the possibility of gaining an overview of the 
patient’s drug use and also of preventing over-pre-
scribing and misuse. Some of the informants also 
found it helpful to receive notifications from the 
electronic prescription system when patients had 
picked up prescriptions in the pharmacy, allowing 
them to monitor adherence. However, on the push 
side another gP strongly expressed frustration related 
to too many alerts by the software indicating drug 
interactions; this was perceived as annoying and 
counterproductive.
These new systems have forced me to go through 
the medication lists frequently. When I use the 
electronic prescription system, the whole medi-
cation list is presented each time I prescribe. I 
can no longer say, “I forgot you were using that 
drug” when talking to a patient. It also forces 
me to reflect on whether the patient really needs 
all these drugs or if I should remove some of 
them. (Male gP, 36 years in practice)
Uncertainty about outcome of change in FRIDs
Handling outcome uncertainty was perceived as a 
factor affecting both the prescribing and the cessa-
tion of FrIDs. To know that a drug might both be 
beneficial and harmful was described as a dilemma. 
When it was considered appropriate to end a FrID, 
decisions were made depending on the class of drug 
and the specific disease. The gPs described incidents 
in which terminating a drug had worsened the 
patient’s condition, but also the opposite when reduc-
ing the number of drugs to a bare minimum made 
the patients blossom. The paradox of not being able 
to predict the outcome of changes in drug treatment 
was perceived as challenging and uncomfortable. 
They found it easier to remove drugs the patient did 
not like, such as antihypertensive drugs, compared 
with psychotropic drugs. They assumed that from the 
patient’s point of view this had to do with the type 
of withdrawal symptoms or absence of such, and also 
with the patient’s experience of the condition being 
treated. The gPs said that the patients might be 
reluctant to terminate psychotropic drugs due to the 
drug being perceived as an assurance in life, and that 
termination of the drug would create great discom-
fort and a nocebo effect. From the gPs’ point of 
view, they found it easier to explain and understand 
the pharmacological causality of adverse drug reac-
tions such as dizziness from antihypertensive drugs 
compared with reactions from psychotropic drugs. 
The knowledge that physiological changes often lead 
to orthostatic hypotension due to ageing itself was 
mentioned as a reason, but it was also perceived as 
easier to examine the possible correlation between 
dizziness and orthostatic hypotension.
I find it is easier to remove antihypertensive 
drugs compared with psychotropic drugs, since 
I better understand the pharmacological correla-
tion between the effect of the drug and the symp-
tom of dizziness. (Male gP. 9 years in practice)
Patients’ demands for prescription
Prescribing demands by the patient were not 
mentioned spontaneously by the gPs. When asked, 
the gPs described the elderly as modest and 
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undemanding compared with younger patients. 
However, they could put some pressure on the gPs, 
e.g. by asking for their annual prescription of sleep-
ing pills just before leaving the consultation room 
leaving little chance for discussion. In addition the 
gPs described situations where the elderly person or 
next-of-kin expressed a deep need for sleeping pills 
and the gP found it unpleasant to say no. One gP 
expressed that he found it easier to say yes and that 
it was a limitation to how many times he had the 
energy to say no during one day. It was described as 
unpleasant to say no, in spite of the drugs’ potential 
side effects, when the gP perceived the drug to be a 
possible solution to the patient’s problems.
Many patients are very fond of their drugs and 
are very reluctant to end the treatment. Then my 
threshold to let them continue is often low. 
(Female gP, 11 years of practice)
It was described as difficult to terminate a drug due 
to a feeling of letting the patient down, especially in 
those patients who had used the drug for a very long 
time. Deeper conversations and pharmacological 
explanations were mentioned as the best approach to 
getting the patient to support the decisions for ter-
mination or dose-reduction of a drug. When the 
patient offered resistance to terminating a psychotro-
pic drug the gPs said they appreciated if they could 
get others to support their decisions, like receiving a 
specialist’s second opinion or that of the next-of-kin. 
They perceived it to be easier for the patient to accept 
a drug termination when more than one professional 
supported the decision.
It might be our bad consciences that make it 
easier to write a prescription. Most patients are 
initially more satisfied if they get one. But if you 
take time to talk, the majority of patients will 
understand that a prescription is not always the 
only possible solution. (Male gP 36 years of 
practice)
The gPs generally agreed that their patients sometimes 
take FrIDs such as psychotropic drugs for too long 
and at too-high dosages. However, this was said to be 
difficult to alter because the gPs perceived that the 
patients were not motivated for change. The driving 
licence regulation was highlighted as a gateway to 
change, as the gPs could use the dose range given in 
the regulation to both explain side effects related to the 
drug’s use and to justify a drug’s termination. By using 
this regulation, they felt they could shift the responsibil-
ity for such a difficult decision onto the authorities.
If I use the driving licence regulation to justify 
termination of a drug, it feels as though it is not 
solely my decision and I am no longer the “exe-
cutioner”. Then they have the choice of either 
keeping their driving licence or the psychotropic 
drug. (Male gP, 8 years in practice)
Not getting all information about the patient
The gPs told of situations where they felt that they 
did not have all the relevant information about the 
patient and this was said to affect both prescribing 
and termination of FrIDs and whether they per-
formed drug reviews. Patients sometimes withheld 
important information concerning side effects from 
the gP, in fear of either being taken off the drug or 
being forced to move home to a nursing home.
The next-of-kin attending the consultation with 
the patient was in this regard viewed as helpful to 
ensure that vital information was available and 
exchanged. The next-of-kin could also help to gain 
better insight before making a decision, especially so 
for patients living in nursing homes.
We need to rely upon our observations and the 
information given by the patient at consulta-
tions. Sometimes we need to act without having 
access to the whole picture. (Male gP, 36 years 
of practice)
Discussion
Drug use was not immediately perceived by the gPs 
as a prominent factor in falls among the elderly. It 
was reported as common practice to renew FrIDs 
without further consideration of the drugs in use. 
Factors such as the gPs’ clinical work conditions, 
uncertainty about outcome of changing prescrip-
tions, patients’ prescribing demands, and lack of 
patient information were also found to affect pre-
scribing and cessation of FrIDs and whether a drug 
review was performed.
Strengths and limitations
The strength of this study was the wide variation in 
the sample regarding working experience, gender, 
and gP offices. Since we used existing CMe groups, 
the interviewees knew each other in advance and this 
might have contributed to a more relaxed and free-
speaking environment. However, any former dis-
agreements might have limited the discussions.
Two of the authors being pharmacists (first and 
last author) with an interest in and experience of issues 
related to appropriate drug prescribing and patient 
empowerment would naturally affect what is empha-
sized in the results. It cannot be ruled out that the gPs 
avoided some points due to social desirability, but our 
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judgement is that we obtained a fair representation of 
their actual opinions, as some of the things that were 
said could be perceived as reflecting negatively upon 
the gPs.
A limitation was that the interviewees came from 
CMe groups in only one city in Norway. Although 
this might hamper the transferability, the findings are 
similar to other studies in other contexts indicating 
that some general themes identified have external 
validity [28]. The numbers of focus groups were low 
and saturation might not be met. However, there are 
similar studies with the same number of focus groups 
and participants [28].
Contribution of FRIDs in falls
The gPs in this study correctly identified some of 
the other central risk factors for falls that have been 
documented in the literature in addition to drug use, 
such as advanced age, previous falls, increased dis-
ability, musculoskeletal problems, and neurological 
diseases [3,29]. Diseases such as depression, heart 
failure, or hypertension may increase fall risk, but so 
also may the drugs used to treat these conditions, 
and the fall risk increases with an increasing number 
of simultaneously occurring chronic diseases and risk 
factors present [25,26,30].
However, the gPs in our study did not consider 
drug use to be an important enough risk factor for 
falls in general to let it affect their habit of renewing 
prescriptions of FrIDs without performing regular 
drug reviews. This is in contrast to research findings, 
in which the use of FrIDs is found to be associated 
with an increased risk of falls even after adjustment 
for comorbid conditions and disability [3]. Several 
others have confirmed the relationship between 
number of prescription drugs and falls, although the 
definition of polypharmacy has varied [25,29,31–33]. 
Higher doses of antihypertensive drugs have been 
shown to be independently associated with falls in 
older people, with a 48% greater risk in those with a 
daily defined dose of more than three, particularly in 
those with a history of stroke [34]. In particular the 
use and dose of psychotropic drugs such as hypnot-
ics/anxiolytics and antidepressants has been linked to 
falls even when adjusted for chronic disease status 
[30,35,36].
In light of both polypharmacy and multimorbid-
ity being factors that increase the risk of falls, it is 
understandable that this complexity might give rise 
to insecurity when assessing the prescribing and ces-
sation of FrIDs for elderly patients. The gPs in our 
study had experienced both favourable and unfa-
vourable results of changing prescription, creating 
an uncertainty about which outcome to expect and 
an attitude that it might be better not to change 
prescriptions and therefore to renew prescriptions of 
FrIDs. Whether this is anchored in a fear of making 
mistakes was not further looked into in this study, 
but other studies has showed that there exist “non-
pharmacological” prescribing reasons [11,37].
Different tools have been developed to assist 
gPs in these complex situations such as the Beer 
criteria [38], the STArT/STOP criteria [18], and 
the NOrgeP criteria [17]. There is less research 
performed on assisting best-practice de-prescribing 
[39] and the lack of such research might have an 
impact on gPs’ habit of keeping the status quo and 
not terminating possibly inappropriate drugs. The 
gPs in this study reported being more influenced 
on cessation of FrIDs from national prescribing 
support initiatives than guidelines since the latter 
were perceived as not suitable. This is consistent 
with other research showing that external validity 
of research evidence-based guidelines is perceived 
as problematic in general practice [40]. Both the 
e-prescription system and the driving licence regula-
tion were perceived by the gPs as of great value. By 
using the driving licence regulation they felt they 
could shift the responsibility of the difficult decision 
on to the government. This was in contrast to when 
they used guidelines and criteria and might felt that 
they had to vouch for the decision by themselves. 
This might indicate a greater wish for shared deci-
sion-making than revised guidelines.
Regular drug reviews
Our results indicate that gPs do not necessarily fol-
low the precautionary principle when prescribing 
FrIDs to the elderly. research has shown that 
drug-related events such as falls are often associated 
with unnecessary prescriptions [41], too long a 
duration of drug treatment [42], and the lack of 
drug reviews on repeated prescriptions [43]. It has 
been stated that it is important to review the 
indications and evidence for continuing long-stand-
ing drugs on a regular basis for elderly patients 
[44–47] and re-evaluation of drug therapy has been 
mentioned by several authors as one of the major 
prevention strategies against falls [48,49]. A thorough 
anamnesis, regular blood pressure control, and regu-
lar drug reviews have been suggested to be obligatory 
tasks to prevent falls in all parts of the health care 
system [50].
Since the gPs in this study did not spontaneously 
comment on the drug-review paragraph in the new 
gP legislation, and the reimbursement connected to 
it [21], there is still an open question as to whether 
this will lead to regular drug reviews. The gPs stated 
that they appreciated hospital discharge letters 
where someone at the hospital had performed a 
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drug review and made suggestions for alteration. 
This might indicate that the gPs could be open to 
accept input on their drug care from others.
Drug reviews can be performed by gPs alone or 
supported by other health personnel, such as nurses 
and pharmacists [51]. Drug-review interventions 
where clinical pharmacists have formulated priori-
tized written recommendations to the gP have been 
associated with reductions in inappropriate prescrib-
ing in older outpatients showing a reduction of 24% 
compared with 6% in the control group [52]. In 
another study community pharmacists met with gPs 
to discuss possible drug changes based on clinical 
drug reviews. This showed a significantly improved 
Medication Appropriateness Index in the interven-
tion group [53]. In light of the results of this study, 
where the gPs appreciated the ability of support in 
difficult situations, receiving input from other health 
personnel on possible changes in prescribing and 
cessation of FrIDs might be a reasonable way to 
reduce inappropriate prescribing of these drugs.
The results from this study indicate that gPs 
need to be reminded that there is a connection 
between FrID use and falls among elderly patients 
of enough clinical relevance to remember to assess 
the patient’s drug list and perform drug reviews on 
a regular basis.
One way to change gPs’ behaviour could be to 
offer the gPs help with reviewing their patients’ pre-
scriptions and suggest alterations.
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